Boston Angel Investors →
VP of Research and Special Initiatives, Google
Founder and Managing Director of DEV
Chairman, CEO, & Founder, Alexandria Real Estate Equities
President & CEO, Indiana Biosciences Research Institute
Founder and CEO, Acme Packet
Professor, Michigan State University
Director, Silicon Flatirons Centers' Entrepreneurship Initiative
Managing Partner at Pappas Ventures
October 20, 2016 ·
October 27, 2016 ·
November 17, 2016 ·
Cytokinetics (NASDAQ: CYTK) is a South San Francisco-based drug company developing treatments for neurological conditions such as amyotrophic lateral sclerosis (Lou Gehrig’s Disease).
WEDC’s QNBV Program sets up entrepreneurs for success
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.
© 2007-2016, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.